JP Morgan analyst John Stansel maintains Evolent Health (NYSE:EVH) with a Overweight and raises t

TD Cowen analyst Charles Rhyee maintains Evolent Health (NYSE:EVH) with a Buy and raises the pric

Evolent Health, Inc. is awarded a contrarian Buy rating despite extreme indebtedness and recent net

Dimensional Fund Advisors LP reduced its stake in Evolent Health, Inc (NYSE: EVH) by 22.4% during th

Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Hold and low

Citigroup analyst Daniel Grosslight upgrades Evolent Health (NYSE:EVH) from Neutral to Buy and lo

Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's af

Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and lowers

Evolent Health NYSE: EVH reported second-quarter revenue of $653 million, up 31% from the first quar

Evolent Health, Inc. (EVH) Q2 2026 Earnings Call Transcript

While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business per

Evolent Health (EVH) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensu

Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 86.9% to $1.25 during Thursday's

Evolent Health (NYSE:EVH) raises FY2026 sales outlook from $2.400 billion-$2.600 billion to $2.600 b

Evolent Health (NYSE:EVH) reported quarterly earnings of $0.02 per share which beat the analyst cons

WASHINGTON, Aug. 6, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company

TD Cowen analyst Charles Rhyee maintains Evolent Health (NYSE:EVH) with a Buy and lowers the pric

Citigroup analyst Daniel Grosslight downgrades Evolent Health (NYSE:EVH) from Buy to Neutral and

Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and raises

The “Mag Seven” has become the “Bag Seven.” Sharp tech investors are looking elsewhere.

Healthcare IT is emerging as AI's next growth story as providers adopt AI to cut costs & improve car

WASHINGTON, July 8, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achi

Evolent Health, Inc (EVH) is looking like an interesting pick from a technical perspective, as the c

Truist Securities analyst Jailendra Singh downgrades Evolent Health (NYSE:EVH) from Buy to Hold a

Evolent Health (EVH) witnessed a jump in share price last session on above-average trading volume. T

Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Buy and rais

Stocks had mixed performance on Thursday, Dow Jones up 793 points while Nasdaq down 232 points. Rumb

Healthcare payrolls keep climbing, and hospital systems, payers, and clinics are now openly treating

Citigroup analyst Daniel Grosslight maintains Evolent Health (NYSE:EVH) with a Buy and raises the

Evolent Health NYSE: EVH reported first-quarter 2026 results that management said were in line with

Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript

Needham analyst Matthew Shea maintains Evolent Health (NYSE:EVH) with a Buy and raises the price

While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business per

Evolent Health (EVH) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Es

Evolent Health (NYSE:EVH) affirms FY2026 sales outlook from $2.400 billion-$2.600 billion to $2.400

Evolent Health (NYSE:EVH) reported quarterly losses of $(0.02) per share which beat the analyst cons

WASHINGTON, May 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"

U.S. stocks were lower, Dow Jones fell 0.1% on Monday. XOMA shares rose on Ligand's plans to acq

WASHINGTON, April 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on ach

Evolent Health, Inc (NYSE: EVH - Get Free Report) has earned an average rating of "Moderate Buy" fro

Oppenheimer analyst Michael Wiederhorn maintains Evolent Health (NYSE:EVH) with a Outperform and

Citigroup analyst Daniel Grosslight maintains Evolent Health (NYSE:EVH) with a Buy and lowers the

UBS analyst Kevin Caliendo maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price ta

Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Buy and lowe

Needham analyst Matthew Shea maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price

RBC Capital analyst Ryan Halsted maintains Evolent Health (NYSE:EVH) with a Sector Perform and lo

BTIG analyst David Larsen maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price tar

Evolent Health (NYSE:EVH) reported quarterly earnings of $0.08 per share which beat the analyst cons